VKTX · CIK 0001607678 · operating
Viking Therapeutics, Inc. (VKTX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $3.9 billion, Viking Therapeutics, Inc. is a mid-cap company. The stock currently trades at $33.34, down 1.48% today, with a 52-week range of $18.92–$43.15.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-3.19 | $-3.19 | -215.8% | |
| 2024 | $-1.01 | $-1.01 | -11.0% | |
| 2023 | $-0.91 | $-0.91 | -1.1% | |
| 2022 | $-0.90 | $-0.90 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-11 | 0001193125-26-046876 | SEC ↗ |
| 2024-12-31 | 2025-02-26 | 0000950170-25-027824 | SEC ↗ |
| 2023-12-31 | 2024-02-07 | 0000950170-24-012322 | SEC ↗ |
| 2022-12-31 | 2023-02-10 | 0001564590-23-001685 | SEC ↗ |
| 2021-12-31 | 2022-02-09 | 0001564590-22-004429 | SEC ↗ |
| 2020-12-31 | 2021-02-17 | 0001564590-21-006406 | SEC ↗ |
| 2019-12-31 | 2020-02-26 | 0001564590-20-006766 | SEC ↗ |
| 2018-12-31 | 2019-03-13 | 0001564590-19-007584 | SEC ↗ |
| 2017-12-31 | 2018-03-07 | 0001564590-18-004757 | SEC ↗ |
| 2016-12-31 | 2017-03-21 | 0001564590-17-004911 | SEC ↗ |
| 2015-12-31 | 2016-03-08 | 0001564590-16-014212 | SEC ↗ |